CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the role of mRNA methylation in the survival of dopamine neurons affected by Parkinson's disease. Researchers aim to develop new therapeutic compounds that enhance m6A levels, potentially offering innovative treatment options that protect and regenerate neurons, addressing both the biological…
Parkinson’s disease (PD) is a neurodegenerative disease with growing incidence.
More than 10 million people worldwide are affected by this condition.
In addition to decline in the patients’ quality of life, the economic burden of PD is estimated to exceed 13,9 billion EUR in EU annually.
Considering this, novel and more efficient therapeutic options are needed, as current PD treatments alleviate symptoms without stopping neurodegeneration and progression of the disease.
Although the etiology of…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
